Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice

Journal of Clinical Investigation

Volumn 119, Issue 11, 2009, Pages 3236-3245

  Stanford, Kristin I ^a,b   Bishop, Joseph R ^a   Foley, Erin M ^a,b   Gonzales, Jon C ^a,b   Niesman, Ingrid R ^a   Witztum, Joseph L ^c   Esko, Jeffrey D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; HEPARIN; SYNDECAN 1; SYNDECAN 2; SYNDECAN 4; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAT INTAKE; FEMALE; HYPERTRIGLYCERIDEMIA; LIPID LIVER LEVEL; LIVER CELL; LIVER CLEARANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ANIMALS; CELLS, CULTURED; DIETARY FATS; HEPATOCYTES; HUMANS; LIPOPROTEINS; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROVILLI; SYNDECAN-1; TRIGLYCERIDES;

EID: 70449408083     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38251     Document Type: Article

References (76)

1. Nordestgaard, B.G., Benn, M., Schnohr, P., and Tybjaerg-Hansen, A. 2007. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 298:299-308. (Pubitemid 47080484)
2. Bansal, S., et al. 2007. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 298:309-316. (Pubitemid 47080485)
3. Beigneux, A.P., et al. 2007. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 5:279-291.
4. Young, S.G., et al. 2007. GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons. Curr. Opin. Lipidol. 18:389-396.
5. Williams, K.J., and Fuki, I.V. 1997. Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism. Curr. Opin. Lipidol. 8:253-262.
6. Mahley, R.W., and Ji, Z.S. 1999. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40:1-16.
7. Mahley, R.W., and Huang, Y. 2007. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. J. Clin. Invest. 117:94-98. (Pubitemid 46048456)
8. Williams, K.J. 2008. Molecular processes that handle - and mishandle - dietary lipids. J. Clin. Invest. 118:3247-3259.
9. MacArthur, J.M., et al. 2007. Liver heparan sulfate proteoglycans mediate clearance of triglyceriderich lipoproteins independently of LDL receptor family members. J. Clin. Invest. 117:153-164.
10. Bishop, J.R., Stanford, K.I., and Esko, J.D. 2008. Heparan sulfate proteoglycans and triglyceriderich lipoprotein metabolism. Curr. Opin. Lipidol. 19:307-313. (Pubitemid 351653570)
11. Shintani, Y., et al. 2006. Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J. 25:3045-3055. (Pubitemid 44106757)
12. Bishop, J.R., Schuksz, M., and Esko, J.D. 2007. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature. 446:1030-1037. (Pubitemid 46676065)
13. Fuki, I.V., et al. 1997. The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. J. Clin. Invest. 100:1611-1622.
14. Fuki, I.V., Iozzo, R.V., and Williams, K.J. 2000. Perlecan heparan sulfate proteoglycan - A novel receptor that mediates a distinct pathway for ligand catabolism. J. Biol. Chem. 275:25742-25750. (Pubitemid 30687078)
15. Wilsie, L.C., Gonzales, A.M., and Orlando, R.A. 2006. Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, nonclathrin- mediated pathway. Lipids Health Dis. 5:23.
16. Williams, K.J. 2001. Interactions of lipoproteins with proteoglycans. Methods Mol. Biol. 171:457-477.
17. Ebara, T., et al. 2000. Delayed catabolism of apoB48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. J. Clin. Invest. 105:1807-1818. (Pubitemid 30421762)
18. Tran-Lundmark, K., et al. 2008. Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation. Circ. Res. 103:43-52.
19. Zeng, B.J., Mortimer, B.C., Martins, I.J., Seydel, U., and Redgrave, T.G. 1998. Chylomicron remnant uptake is regulated by the expression and function of heparan sulfate proteoglycan in hepatocytes. J. Lipid Res. 39:845-860. (Pubitemid 28163285)
20. Yu, K.C., Chen, W., and Cooper, A.D. 2001. LDL receptor-related protein mediates cell-surface clustering and hepatic sequestration of chylomicron remnants in LDLR-deficient mice. J. Clin. Invest. 107:1387-1394. (Pubitemid 32522032)
21. Fuki, I.V., Meyer, M.E., and Williams, K.J. 2000. Transmembrane and cytoplasmic domains of syndecan mediate a multi-step endocytic pathway involving detergent-insoluble membrane rafts. Biochem. J. 351:607-612.
22. Cortes, V., et al. 2007. Adenovirus-mediated hepatic syndecan-1 overexpression induces hepatocyte proliferation and hyperlipidaemia in mice. Liver Int. 27:569-581. (Pubitemid 46534579)
23. Weiner, O.H., Zoremba, M., and Gressner, A.M. 1996. Gene expression of syndecans and betaglycan in isolated rat liver cells. Cell Tissue Res. 285:11-16. (Pubitemid 26257620)
24. Ishibashi, S., et al. 1996. Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both. J. Biol. Chem. 271:22422-22427. (Pubitemid 26304676)
25. Horton, J.D., et al. 1999. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipidrich VLDL. J. Clin. Invest. 103:1067-1076.
26. Alexander, C.M., et al. 2000. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat. Genet. 25:329-332.
27. Hirano, T., et al. 2001. Apoprotein C-III deficiency markedly stimulates triglyceride secretion in vivo: comparison with apoprotein E. Am. J. Physiol. Endocrinol. Metab. 281:E665-E669. (Pubitemid 32948133)
28. Weinstein, M.M., et al. 2008. Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice. J. Biol. Chem. 283:34511-34518.
29. Ishibashi, S., et al. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:883-893. (Pubitemid 23262411)
30. Hayashi, K., et al. 1987. Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study. J. Histochem. Cytochem. 35:1079-1088.
31. Roskams, T., et al. 1995. Heparan sulfate proteoglycan expression in normal human liver. Hepatology. 21:950-958.
32. Higazi, A.A., et al. 2000. The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis. Blood. 96:1393-1398.
33. Anisfeld, A.M., et al. 2003. Syndecan-1 expression is regulated in an isoform-specific manner by the farnesoid-X receptor. J. Biol. Chem. 278:20420-20428.
34. Williams, K.J., et al. 1992. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J. Biol. Chem. 267:13284-13292.
35. Ji, Z.S., et al. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268:10160-10167. (Pubitemid 23150196)
36. 212 - >Lys): Increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts. J. Lipid Res. 37:1632-1645.
37. Krapp, A., et al. 1996. Hepatic lipase mediates the uptake of chylomicrons and β-VLDL into cells via the LDL receptor-related protein (LRP). J. Lipid Res. 37:926-936. (Pubitemid 26182327)
38. Al-Haideri, M., et al. 1997. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations. Biochemistry. 36:12766-12772. (Pubitemid 27465386)
39. Huff, M.W., et al. 1997. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans. J. Lipid Res. 38:1318-1333.
40. Ji, Z.S., Pitas, R.E., and Mahley, R.W. 1998. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4. J. Biol. Chem. 273:13452-13460.
41. Seo, T., et al. 2000. Lipoprotein lipase-mediated selective uptake from low density lipoprotein requires cell surface proteoglycans and is independent of scavenger receptor class B type 1. J. Biol. Chem. 275:30355-30362. (Pubitemid 30751351)
42. Medh, J.D., et al. 2000. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism. J. Lipid Res. 41:1858-1871.
43. Bernfield, M., et al. 1992. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8:365-393. (Pubitemid 23001002)
44. Bernfield, M., et al. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68:729-777. (Pubitemid 29449208)
45. Park, P.W., Reizes, O., and Bernfield, M. 2000. Cell surface heparan sulfate proteoglycans: Selective regulators of ligand-receptor encounters. J. Biol. Chem. 275:29923-29926. (Pubitemid 30751292)
46. Bellin, R., et al. 2002. Unlocking the secrets of syndecans: Transgenic organisms as a potential key. Glycoconj. J. 19:295-304. (Pubitemid 37174558)
47. Sanderson, R.D., and Yang, Y. 2008. Syndecan-1: a dynamic regulator of the myeloma microenvironment. Clin. Exp. Metastasis. 25:149-159.
48. Bartlett, A.H., Hayashida, K., and Park, P.W. 2007. Molecular and cellular mechanisms of syndecans in tissue injury and inflammation. Mol. Cells. 24:153-166. (Pubitemid 350177174)
49. Tumova, S., Woods, A., and Couchman, J.R. 2000. Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int. J. Biochem. Cell Biol. 32:269-288. (Pubitemid 30069970)
50. Burbach, B.J., Friedl, A., Mundhenke, C., and Rapraeger, A.C. 2003. Syndecan-1 accumulates in lysosomes of poorly differentiated breast carcinoma cells. Matrix Biol. 22:163-177. (Pubitemid 36627474)
51. Fitzgerald, M.L., Wang, Z.H., Park, P.W., Murphy, G., and Bernfield, M. 2000. Shedding of syndecan-1 and-4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J. Cell Biol. 148:811-824. (Pubitemid 30679696)
52. Parthasarathy, N., et al. 1994. Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. J. Biol. Chem. 269:22391-22396. (Pubitemid 24282175)
53. Spillmann, D., Lookene, A., and Olivecrona, G. 2006. Isolation and characterization of low sulfated heparan sulfate sequences with affinity for lipoprotein lipase. J. Biol. Chem. 281:23405-23413. (Pubitemid 44274115)
54. Libeu, C.P., et al. 2001. New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. J. Biol. Chem. 276:39138-39144. (Pubitemid 37371284)
55. Dong, J., et al. 2001. Interaction of the N-terminal domain of apolipoprotein E4 with heparin. Biochemistry. 40:2826-2834. (Pubitemid 32198284)
56. Lyon, M., Deakin, J.A., and Gallagher, J.T. 1994. Liver heparan sulfate structure. A novel molecular design. J. Biol. Chem. 269:11208-11215. (Pubitemid 24200329)
57. Vongchan, P., et al. 2005. Structural characterization of human liver heparan sulfate. Biochim. Biophys. Acta. 1721:1-8. (Pubitemid 40093506)
58. Thankamony, S.P., and Knudson, W. 2006. Acylation of CD44 and its association with lipid rafts are required for receptor and hyaluronan endocytosis. J. Biol. Chem. 281:34601-34609. (Pubitemid 46036666)
59. Tkachenko, E., Lutgens, E., Stan, R.V., and Simons, M. 2004. Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway. J. Cell Sci. 117:3189-3199. (Pubitemid 39139905)
60. Brown, M.S., Anderson, R.G., and Goldstein, J.L. 1983. Recycling receptors: the round-trip itinerary of migrant membrane proteins. Cell. 32:663-667.
61. Rohlmann, A., Gotthardt, M., Hammer, R.E., and Herz, J. 1998. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J. Clin. Invest. 101:689-695. (Pubitemid 28084254)
62. Wilsie, L.C., and Orlando, R.A. 2003. The low density lipoprotein receptor-related protein complexes with cell surface heparan sulfate proteoglycans to regulate proteoglycan-mediated lipoprotein catabolism. J. Biol. Chem. 278:15758-15764.
63. Magoori, K., et al. 2003. Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E. J. Biol. Chem. 278:11331-11336. (Pubitemid 36792690)
64. Belting, M. 2003. Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem. Sci. 28:145-151. (Pubitemid 36293852)
65. Elson-Schwab, L., et al. 2007. Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway. J. Biol. Chem. 282:13585-13591. (Pubitemid 47100528)
66. Park, P.W., Pier, G.B., Hinkes, M.T., and Bernfield, M. 2001. Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature. 411:98-102. (Pubitemid 32428197)
67. Reizes, O., et al. 2001. Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell. 106:105-116. (Pubitemid 32709962)
68. Echtermeyer, F., et al. 2001. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107:R9-R14. (Pubitemid 32096841)
69. Seglen, P.O. 1976. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29-83.
70. Hayashida, K., Johnston, D.R., Goldberger, O., and Park, P.W. 2006. Syndecan-1 expression in epithelial cells is induced by transforming growth factor beta through a PKA-dependent pathway. J. Biol. Chem. 281:24365-24374. (Pubitemid 44274208)
71. Dulbecco, R., and Vogt, M. 1954. Plaque formation and isolation of pure cell lines with poliomyelitis viruses. J. Exp. Med. 99:167-182.
72. Rohlmann, A., Gotthardt, M., Willnow, T.E., Hammer, R.E., and Herz, J. 1996. Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nat. Biotechnol. 14:1562-1565. (Pubitemid 26365549)
73. Bishop, J.R., and Esko, J.D. 2005. The elusive role of heparan sulfate in Toxoplasma gondii infection. Mol. Biochem. Parasitol. 139:267-269. (Pubitemid 40128222)
74. Livak, K.J., and Schmittgen, T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402-408. (Pubitemid 34164012)
75. Young, S.G., Smith, R.S., Hogle, D.M., Curtiss, L.K., and Witztum, J.L. 1986. Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B. Clin. Chem. 32:1484-1490.
76. Salacinski, P.R., McLean, C., Sykes, J.E., Clement- Jones, V.V., and Lowry, P.J. 1981. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal. Biochem. 117:136-146. (Pubitemid 12211794)